Literature DB >> 15849849

Increased Th1 and Th2 immune reactivity with relative Th2 dominance in patients with acute exacerbation of schizophrenia.

Bojana Avgustin1, Branka Wraber, Rok Tavcar.   

Abstract

AIM: To determine concentration of T helper (Th(1)) cytokines and Th(2) cytokines in patients with acute exacerbation of schizophrenia and compare the cytokine profiles between subtypes of schizophrenia.
METHOD: One hundred inpatients with acute exacerbation of schizophrenia and 34 matched healthy subjects from the same population without psychiatric history were included in the study. According to predominant symptom complexes the patients were divided into three subgroups: hallucinations and delusions (n=36); disorganized behavior (n=33), and primary, enduring negative or deficit symptoms (n=31). In vitro IFN-gamma and IL-4 secretion by peripheral blood mononuclear cells after stimulation with ionomycin and phorbol 12 myristate 13 acetate was measured by enzyme-linked immunosorbent assay (ELISA) tests.
RESULTS: Significant increase in in vitro secretion of IFN-gamma (21,505 vs 14,915 pg/mL; P=0.037; independent samples t test) and IL-4 (32 vs 15 pg/mL; P<0.001) with a shift to the Th(2) (1,022 vs 1,432 pg/mL; P=0.005) immune response was observed in patients with schizophrenia compared to healthy controls. We found pronounced effects of age and age at first hospitalisation on the Th(1)/Th(2) immune balance (R(2)=0.068; P=0.037). There were no significant differences in in vitro secretion of IFN-gamma (P=0.734; one-way analysis of variance), IL-4 (P=0.485) and IFN-gamma/IL-4 ratio (P=0.293) between the subgroups of patients with schizophrenia.
CONCLUSION: Our findings indicate a simultaneous increase of in vitro reactivity of both Th(1) and Th(2) arm of cell mediated immunity, with a relative predominance of Th(2) immunity in patients with acute exacerbation of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15849849

Source DB:  PubMed          Journal:  Croat Med J        ISSN: 0353-9504            Impact factor:   1.351


  13 in total

1.  Interaction between interleukin 3 and dystrobrevin-binding protein 1 in schizophrenia.

Authors:  Todd L Edwards; Xu Wang; Qi Chen; Brandon Wormly; Brien Riley; F Anthony O'Neill; Dermot Walsh; Marylyn D Ritchie; Kenneth S Kendler; Xiangning Chen
Journal:  Schizophr Res       Date:  2008-09-18       Impact factor: 4.939

2.  Inflammation in Schizophrenia: Cytokine Levels and Their Relationships to Demographic and Clinical Variables.

Authors:  Ellen E Lee; Suzi Hong; Averria Sirkin Martin; Lisa T Eyler; Dilip V Jeste
Journal:  Am J Geriatr Psychiatry       Date:  2016-10-17       Impact factor: 4.105

Review 3.  Functional Implications of the IL-23/IL-17 Immune Axis in Schizophrenia.

Authors:  Monojit Debnath; Michael Berk
Journal:  Mol Neurobiol       Date:  2016-11-29       Impact factor: 5.590

4.  Association study of interleukin-4 polymorphisms with paranoid schizophrenia in the Polish population: a critical approach.

Authors:  Anna Fila-Danilow; Krzysztof Kucia; Malgorzata Kowalczyk; Aleksander Owczarek; Monika Paul-Samojedny; Paulina Borkowska; Renata Suchanek; Jan Kowalski
Journal:  Mol Biol Rep       Date:  2012-04-24       Impact factor: 2.316

5.  Systems biological assessment of altered cytokine responses to bacteria and fungi reveals impaired immune functionality in schizophrenia.

Authors:  Yuan Gao; Yajuan Fan; Zai Yang; Qingyan Ma; Binbin Zhao; Xiaoyan He; Fengjie Gao; Li Qian; Wei Wang; Ce Chen; Yunchun Chen; Chengge Gao; Xiancang Ma; Feng Zhu
Journal:  Mol Psychiatry       Date:  2021-11-02       Impact factor: 15.992

6.  Association study of interleukin 2 (IL2) and IL4 with schizophrenia in a Japanese population.

Authors:  Yuichiro Watanabe; Ayako Nunokawa; Masako Shibuya; Naoshi Kaneko; Hiroyuki Nawa; Toshiyuki Someya
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06-20       Impact factor: 5.270

7.  An association study of the signal transducer and activator of transcription 6 gene with periodic psychosis.

Authors:  Seiya Kawashige; Tetsufumi Kanazawa; Atsushi Tsutsumi; Hiroki Kikuyama; Hiroyuki Uenishi; Jun Koh; Hiroshi Yoneda
Journal:  Psychiatry Investig       Date:  2008-03-31       Impact factor: 2.505

8.  Influence of conjugated linoleic acid on the porcine immune response and morbidity: a randomized controlled trial.

Authors:  Tomaz Malovrh; Lidija Kompan; Polona Juntes; Branka Wraber; Alenka Spindler-Vesel; Drago Kompan
Journal:  Lipids Health Dis       Date:  2009-06-22       Impact factor: 3.876

9.  Comparison of peripheral and central schizophrenia biomarker profiles.

Authors:  Laura W Harris; Sandra Pietsch; Tammy M K Cheng; Emanuel Schwarz; Paul C Guest; Sabine Bahn
Journal:  PLoS One       Date:  2012-10-30       Impact factor: 3.240

10.  Genetic variants in transforming growth factor-β gene (TGFB1) affect susceptibility to schizophrenia.

Authors:  Dorota Frydecka; Blazej Misiak; Jan Aleksander Beszlej; Lidia Karabon; Edyta Pawlak-Adamska; Anna Tomkiewicz; Anna Partyka; Anna Jonkisz; Andrzej Kiejna
Journal:  Mol Biol Rep       Date:  2013-09-25       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.